Literature DB >> 18385568

Atypical radiological manifestation of pulmonary metastatic calcification.

Eun Hae Kang1, Eun Sun Kim, Chul Hwan Kim, Soo-Youn Ham, Yu Whan Oh.   

Abstract

Metastatic pulmonary calcification refers to calcium deposition in the normal pulmonary parenchyma and this deposition is secondary to abnormal calcium metabolism. The most common radiologic manifestation consists of poorly-defined nodular opacities that are mainly seen in the upper lung zone. We present here a case of metastatic pulmonary calcification that manifested as atypical, dense, calcium deposition in airspaces within the previously existing consolidation in the bilateral lower lobes, and this process was accelerated by pneumonia-complicated sepsis in a patient with hypercalcemia that was due to hyperparathyroidism.

Entities:  

Mesh:

Year:  2008        PMID: 18385568      PMCID: PMC2627227          DOI: 10.3348/kjr.2008.9.2.186

Source DB:  PubMed          Journal:  Korean J Radiol        ISSN: 1229-6929            Impact factor:   3.500


Metastatic pulmonary calcification is a condition of calcium deposition in the normal pulmonary parenchyma, and this is secondary to abnormal calcium metabolism without any prior soft tissue damage. The predisposing factors for this condition include chronic renal failure, hypercalcemia and increased tissue alkalinity. The most common radiologic manifestation consists of poorly defined nodular opacities in the upper lung zone. These opacities reflect the deposition of calcium salts in the pulmonary interstitium (1-4). We present here a case of metastatic pulmonary calcification in a patient who recovered from pneumonia with sepsis and whose high-resolution CT (HRCT) images demonstrated localized parenchymal airspace calcification that was limited to the bilateral lower lobes. These lower lobes had been involved with pneumonic consolidation without calcification, as seen on the previous CT scan.

CASE REPORT

A 48-year-old female patient presented with weight loss, fever and general weakness for about one month. She had been admitted to another hospital and was diagnosed with hyperparathyroidism. She had had an episode of febrile shock during her hospitalization in that hospital; therefore, she was transferred to our hospital. The initial vital signs at admission were as follows: a blood pressure of 86/54 mmHg, a pulse rate of 136/min, a body temperature of 38.5℃ and a respiratory rate of 28/min. The physical examination demonstrated coarse breathing sounds with crackles in both lower lung zones. She complained of severe dyspnea. The laboratory results were as follows: serum urea 37 mg/dL (normal range: 10-40), creatinine 2.3 mg/dL (normal range: 0.6-1.1), calcium 14.1 mg/dL, ionized calcium 7.8 mg/dL, phosphorus 2.3 mg/dL, intact PTH 635.30 pg/mL and WBC 24,460/mm3. The arterial blood gas analysis values under oxygen therapy via a face mask with a flow rate of 10 L/min were pH 7.235, PaCO2 61.8 mmHg, PaO2 75.9 mmHg, HCO3 25.6 mmol/L and O2 saturation 94%. Admission chest radiograph showed patchy bilateral airspace consolidation that was mainly in the lower lung zones. The precontrast chest CT demonstrated airspace consolidation in the bilateral lower lobes (Fig. 1A) and multifocal patchy ground-glass opacities in both lungs. Neck CT showed a 2.5 × 1.8 cm sized ovoid soft-tissue nodule at the right infrathyroid area, which was suggestive of parathyroid adenoma. Thus, the patient was diagnosed to have hyperparathyroidism-associated hypercalcemia and pneumonia-complicated septic shock. She was moved to the intensive care unit and received mechanical ventilator care with assisted controlled mandatory ventilation (ACMV) and continuous renal replacement therapy (CRRT). She underwent bronchoscopy and bronchoalveolar lavage (BAL) to search for clues for her sepsis, and the result of quantitative culture using the BAL fluid revealed that the pathogen was methicillin-resistant Staphylococcus aureus (MRSA).
Fig. 1

Metastatic calcification in 48-year-old woman.

A. Mediastinal window image of transverse CT scan obtained at level of liver dome and at time of admission shows airspace consolidation in bilateral lower lobes. Note absence of calcification within consolidation at this time.

B. Twenty-seven-day-interval follow-up CT scan obtained at level similar to A and after weaning patient from mechanical ventilation demonstrates well-defined bilateral lower lobar consolidation that contains diffuse tissue deposition of calcium, and this is limited to areas of previous consolidation. In addition, scattered calcium deposition was noticed within myocardium.

C. Anterior and posterior bone scan images show intense mass-like soft tissue uptake (arrows) of Tc-99m MDP in both lower lung zones and diffusely increased uptakes along stomach wall (arrowheads) without any abnormal bone uptake.

D. Alveolar walls are deposited with basophilic spicules of calcium (arrows). Note fibrous tissue within alveolar spaces (Hematoxylin & Eosin staining, ×400).

Parathyroidectomy was performed after she had improved from the sepsis and had been weaned from mechanical ventilation. However, the bilateral pulmonary airspace consolidations remained. Therefore, HRCT was performed to further evaluate the persistent consolidative lesions in the both lower lobes. The follow-up CT demonstrated geographic high-attenuation consolidation and ground-glass opacities with a lower lobe predominance, which was suggestive of metastatic calcifications (Fig. 1B). Bone scintigraphy using Tc-99m methylene diphosphonate (MDP), demonstrated a prominently dense accumulation of the radioactive tracer in the bilateral lower lung zones in the thorax, and diffusely increased uptake was seen along the stomach wall without any abnormal bone uptake; this was all compatible with metastatic calcification (Fig. 1C). She complained of exertional dyspnea and her pulmonary function was compatible with severely restrictive physiology and a low diffusion capacity. She underwent percutaneous lung biopsy and the histologic specimen revealed metastatic pulmonary calcification (Fig. 1D). At the 9th month after surgical resection of the parathyroid, her serum calcium level was maintained within the normal range and her pulmonary function test showed nearly complete recovery to the normal value. She has almost recovered her health without any symptoms.

DISCUSSION

Pathologic pulmonary calcification can be broadly divided into metastatic calcification and dystrophic calcification. Metastatic pulmonary calcification is defined as calcium deposition in normal lung tissue without prior tissue damage and it is secondary to abnormal calcium metabolism. On the other hand, dystrophic calcification requires injured tissues such as infected or inflamed lung for the calcification to occur even in the absence of increased serum calcium levels (5). The predisposing pathophysiologic states for metastatic calcification are reported to be hypercalcemia and a local alkaline environment. For that reason, elevated calcium-phosphate production, including hypercalcemia, is usually discovered in most cases of metastatic calcification (6, 7). Meanwhile, the calcium salts precipitate in an alkaline environment, and so pulmonary calcific disorders have the upper lobe predilection due to the higher blood pH and lower PaCO2 at the apex as compared with the relatively lower pH at the base (5, 8, 9). The radiological findings of metastatic calcification have generally been reported to be centrilobular ground-glass nodular opacities with numerous fluffy, poorly defined nodules that measure 3 to 10 mm in diameter on the high resolution CT scans (1-4). Patchy areas of consolidation that might also simulate pneumonia were reported in a few cases (1). However, our case presented with unusual manifestations in several aspects such as the distribution of lesion and the radiologic findings. For our case, the site of calcification was the base of both lungs where a relatively less alkaline or slightly acidic environment is maintained. In addition, the ectopic calcification of this case occurred at a prior inflamed lung lesion, as opposed to the definition of pulmonary metastatic calcification. Radiologically, our case showed well-defined highly attenuated dense airspace consolidation like that in a report by Hartman et al. (1). So, we have validated another type of metastatic pulmonary calcification that developed in underlying consolidation. We suppose some potential pathophysiologic mechanism in our case, such as the influence by previous cellular and tissue injury as occurs in dystrophic pulmonary calcification, may have contributed to the calcium accumulation in the consolidative lesions in the lower lobes (5). During the process of cellular injury, the pH falls during the early phase and it shifts to a neutral or alkaline pH as the injury continues. The latter state would promote ectopic calcification. Our case had significant predisposing factors for ectopic calcification: excess serum calcium and the continuous tissue injury caused by lobar pneumonia (10). Therefore, this case would correspond to metastatic pulmonary calcification that occurred in her pneumonia-injured tissue. In summary, we report here on an atypical presentation of metastatic pulmonary calcification that showed dense airspace consolidation localized to the bilateral lower lobes in a patient with primary hyperparathyroidism and pneumonia.
  8 in total

1.  Case report. Metastatic pulmonary calcification in renal failure: a new HRCT pattern.

Authors:  R K Lingam; J Teh; A Sharma; E Friedman
Journal:  Br J Radiol       Date:  2002-01       Impact factor: 3.039

2.  Extensive metastatic calcification of the lung in an azotemic patient.

Authors:  M Neff; S Yalcin; S Gupta; H Berger
Journal:  Am J Med       Date:  1974-01       Impact factor: 4.965

Review 3.  Metabolic lung disease: imaging and histopathologic findings.

Authors:  Myung Jin Chung; Kyung Soo Lee; Tomás Franquet; Nestor L Müller; Joungho Han; O Jung Kwon
Journal:  Eur J Radiol       Date:  2005-05       Impact factor: 3.528

4.  Metastatic pulmonary calcification: appearance on high resolution CT.

Authors:  S Greenberg; B Suster
Journal:  J Comput Assist Tomogr       Date:  1994 May-Jun       Impact factor: 1.826

Review 5.  Pulmonary calcifications: a review.

Authors:  D Bendayan; Y Barziv; M R Kramer
Journal:  Respir Med       Date:  2000-03       Impact factor: 3.415

Review 6.  Calcium deposition with or without bone formation in the lung.

Authors:  Edward D Chan; Donald V Morales; Carolyn H Welsh; Michael T McDermott; Marvin I Schwarz
Journal:  Am J Respir Crit Care Med       Date:  2002-06-15       Impact factor: 21.405

7.  Metastatic pulmonary calcification in patients with hypercalcemia: findings on chest radiographs and CT scans.

Authors:  T E Hartman; N L Müller; S L Primack; T Johkoh; N Takeuchi; J Ikezoe; S J Swensen
Journal:  AJR Am J Roentgenol       Date:  1994-04       Impact factor: 3.959

8.  Metastatic pulmonary calcification in a patient with nonsecretory multiple myeloma.

Authors:  H Kempter; G Hagner; A N Savaser; H Huben; C Minguillon
Journal:  Respiration       Date:  1986       Impact factor: 3.580

  8 in total
  4 in total

1.  Metastatic pulmonary calcification in chronic renal failure.

Authors:  K S Madhusudhan; Pratibha S Shad; Sumat Sharma; Ashwini Goel; Harsh Mahajan
Journal:  Int Urol Nephrol       Date:  2011-07-21       Impact factor: 2.370

2.  The calcified lung nodule: What does it mean?

Authors:  Ali Nawaz Khan; Hamdan H Al-Jahdali; Carolyn M Allen; Klaus L Irion; Sarah Al Ghanem; Shyam Sunder Koteyar
Journal:  Ann Thorac Med       Date:  2010-04       Impact factor: 2.219

3.  Metastatic pulmonary calcification.

Authors:  G H Neild; Alexandre Braga Libório; Lorenna Rodrigues; Hânysson Freire de Almeida; Elizabeth F Daher
Journal:  NDT Plus       Date:  2011-07-17

4.  Uremic lung: The "calcified cauliflower" sign in the end stage renal disease.

Authors:  Giuseppe Dilorenzo; Michele Telegrafo; Giuseppe Marano; Michele De Ceglie; Amato Antonio Stabile Ianora; Giuseppe Angelelli; Marco Moschetta
Journal:  Respir Med Case Rep       Date:  2016-10-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.